General anesthesia in gynecological prcedures Pregnancy and Childbirth General anesthesia in gynecological prcedures
Conditions
Interventions
Participants are randomly allocated to one of two groups by computer.
Group 1: Patients are given 0.02 mg/kg midazolam (Dormicum) IV, in addition to IV 1 mcg/kg remifentanil (Ultiva) administered ove
Sponsors
Baskent University Research Fund
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female patients between 18 and 60 years 2. ASA physical status I-II 3. Have undergone dilatation curettage and/or endometrial biopsy procedures
Exclusion criteria
Exclusion criteria: 1. Psycihiatric disorder 2. Opioid drug abusement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Emergence time from general anesthesia is determined by recording time taken for the patient to open their eyes and provide a verbal answer to a question 2. Discharge time from post-anesthesia care unit is determined according to modified Aldrete score at the time of discharge from the post-anesthesia care unit | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain is measured using the visual analog scale post-operatively in the post-anesthesia care unit 2. Additional analgesic requirement (if VAS is upper 5 point) post-operatively in the post-anesthesia care unit 3. Patient satisfaction with anesthesia is measured using the visual analogue scale post-operatively in the post-anesthesia care unit 4. Intra-operative dreaming is measured through patient interviews 10 minutes post-operatively | — |
Countries
Turkey
Outcome results
None listed